Completed EARLY_PHASE1 INTERVENTIONAL 1-arm NCT02481609

NAC Trial for Anosmia

Pilot Study of Topical Intranasal N-acetyl Cysteine Administration for the Treatment of Anosmia

Sponsor: University of Miami

Conditions Anosmia

Updated 8 times since 2017 Last updated: Mar 16, 2018 Started: Jul 31, 2014 Primary completion: Dec 1, 2017 Completion: Dec 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Anosmia and is currently completed. University of Miami leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Apr 2018 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Status: Active Not Recruiting → Completed

▶ Show 3 earlier versions

Feb 2018 — Apr 2018 [monthly]

Active Not Recruiting EARLY_PHASE1

Status: Recruiting → Active Not Recruiting
Feb 2017 — Feb 2018 [monthly]

Recruiting EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Recruiting Phase 0

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Miami

Data source: University of Miami

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Miami, United States